(M30) Polyarteritis nodosa and related conditions

More details coming soon

Icon
186 013 in individuals diagnosis polyarteritis nodosa and related conditions confirmed
Icon
4 451 deaths with diagnosis polyarteritis nodosa and related conditions
Icon
2% mortality rate associated with the disease polyarteritis nodosa and related conditions

Diagnosis polyarteritis nodosa and related conditions is diagnosed Men are 2.88% more likely than Women

95 684

Men receive the diagnosis polyarteritis nodosa and related conditions

2 438 (2.5 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
90 329

Women receive the diagnosis polyarteritis nodosa and related conditions

2 013 (2.2 %)

Died from this diagnosis.

Risk Group for the Disease polyarteritis nodosa and related conditions - Men and Women aged 0-5

Icon
In Men diagnosis is most often set at age 0-94
Icon
Less common in men the disease occurs at Age 95+Less common in women the disease occurs at Age 95+
Icon
In Women diagnosis is most often set at age 0-94

Disease Features polyarteritis nodosa and related conditions

Icon
Absence or low individual and public risk
Icon

Polyarteritis nodosa and related conditions - what does this mean

Polyarteritis nodosa and related conditions are a group of autoimmune diseases that cause inflammation of the small and medium-sized blood vessels. this inflammation can cause symptoms such as abdominal pain, rash, fever, and fatigue, and can lead to organ damage if left untreated.

What happens during the disease - polyarteritis nodosa and related conditions

Polyarteritis nodosa and related conditions are caused by an abnormal immune response that leads to inflammation and damage to small and medium-sized arteries. this can lead to a variety of symptoms including fever, weakness, abdominal pain, rash, and joint pain. over time, the inflammation can cause the walls of the arteries to become thickened and narrowed, leading to decreased blood flow and tissue damage. in some cases, the inflammation can also affect other organs in the body, such as the kidneys, heart, and lungs.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Physical Examination
  • Laboratory Tests
    • Complete Blood Count (CBC)
    • Erythrocyte Sedimentation Rate (ESR)
    • Serum Protein Electrophoresis (SPEP)
    • Serum Immunoglobulins
    • C-Reactive Protein (CRP)
    • Antinuclear Antibody (ANA) Test
    • Hepatitis B Serology
    • Complement Levels
  • Imaging Studies
    • X-Ray
    • Computed Tomography (CT) Scan
    • Magnetic Resonance Imaging (MRI)
  • Angiography
  • Biopsy
  • Pulmonary Function Tests

Treatment and Medical Assistance

Main Goal: To reduce inflammation and prevent organ damage
  • Prescribing corticosteroids to reduce inflammation
  • Prescribing immunosuppressive medications to suppress the immune system
  • Administering plasmapheresis to remove antibodies from the blood
  • Undergoing surgery to remove damaged tissue
  • Engaging in physical therapy to improve mobility
  • Participating in lifestyle changes such as avoiding smoking, eating a healthy diet, and exercising regularly
  • Receiving regular checkups to monitor the condition
Icon
16 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Polyarteritis nodosa and related conditions - Prevention

Prevention of polyarteritis nodosa and related conditions involves avoiding contact with environmental toxins, maintaining a healthy lifestyle, managing stress levels, and receiving regular check-ups and screenings to detect any early signs of the condition. additionally, vaccinations against certain viral infections can help reduce the risk of developing the condition.

Specified forms of the disease

(R57.0) Cardiogenic shock
(R57.1) Hypovolaemic shock
(R57.8) Other shock
(R57.9) Shock, unspecified